RPG Life Sciences Announces Subsidiary Merger of Actis Generics into RPG Active Pharma
RPG Life Sciences Ltd · Others (Uncategorized) · 26 Sept 2026, 5:46 am
RPG Life Sciences Announces Subsidiary Merger of Actis Generics into RPG Active Pharma RPG Life Sciences' subsidiary, RPG Active Pharma Limited (RPGAP; net worth INR 34.75 Cr as of 31st Mar'26), approved the amalgamation of its wholly owned subsidiary, Actis Generics Private Limited (net worth INR 34.60 Cr, FY26 revenue INR 45.96 Cr), into RPGAP under Sections 230–232 of the Companies Act, 2013. The merger involves no cash consideration or share issuance, as all Actis Generics shares will be cancelled. The move aims to streamline corporate structure, optimize capital, and enhance operational efficiencies without changing RPG Life Sciences' shareholding pattern.
Original exchange filing (PDF)
More announcements from RPG Life Sciences Ltd
- Earning call Transcript · 05 Nov 2026
- Audio Recording of Q2FY27 Results Earnings Call held on October 30, 2026 · 31 Oct 2026
- Investor Presentation · 30 Oct 2026
- Amendment to Policy on Related Party Transactions · 30 Oct 2026
- Press Release · 30 Oct 2026
- Outcome of Board Meeting held on October 29, 2026. · 30 Oct 2026
- Financial Result for the quarter ended September 30, 2026 · 30 Oct 2026
- Outcome of Board Meeting · 30 Oct 2026
